Olgasi, C., Cucci, A
Eur J Gen Pract (2006) 12(4):16973.10.1080/14017430601049449 24 Sanz-CuestaTGonzalez-EscobarPRiesgo-FuertesRGarrido-ElustondoSdel Cura-GonzalezIMartin-FernandezJet alOral versus intramuscular administration of vitamin B12 for the treatment of patients with vitamin B12 deficiency: a pragmatic, randomised, multicentre, non-inferiority clinical trial undertaken in the primary healthcare setting (project OB12)
Great product easy to use and very helpful staff Quick delivery and a great product
The pharmaceutical formulation disclosed herein may comprise 10-25% w/v, such as more than 10% w/v and less than 22% w/v, such as about 10-20% w/v, such as about 12- 18% w/v, such as about 10-17.5% w/v, such as about 11.25-15%, such as about 15% w/v hydroxypropyl-beta-cyclodextrin having a minimum of about 0.4 hydroxypropyls per glucose unit and a maximum of about 1.0 hydroxypropyls per glucose unit
One of the best things about BPC-157 is that it is orally bioavailable, particularly the arginate salt we use, is extremely stable